Miller R D, Huckstep L L, McDermott J P, Queener S W, Kukolja S, Spry D O, Elzey T K, Lawrence S M, Neuss N
J Antibiot (Tokyo). 1981 Aug;34(8):984-93. doi: 10.7164/antibiotics.34.984.
A new cepham metabolite has been isolated from the filtered broth of Cephalosporium acremonium by high performance liquid chromatography (HPLC) and identified as 7 beta-(5-D-amino-adipamido)-3 beta-hydroxy-3 alpha-methyl-cepham-4 alpha-carboxylic acid (I). Pure penicillin N was prepared using HPLC in the analytical mode. When I was added in place of penicillin N as substrate for the cell-free biosynthetic of cephalosporin, no formation of deacetoxycephalosporin C (II) was observed. A synthetic cepham derivative, 7 beta-(5-D-aminoadipamido)-3-exomethylene-cepham-4 alpha-carboxylic acid (III) was also tested in the cell-free system as a possible intermediate. The compound III was shown to be an inhibitor of the ring expansion enzyme that converts penicillin N to deacetoxycephalosporin C.
通过高效液相色谱法(HPLC)从顶头孢霉的过滤肉汤中分离出一种新的头孢菌素代谢物,并鉴定为7β-(5-D-氨基己二酰胺基)-3β-羟基-3α-甲基-头孢烷-4α-羧酸(I)。使用分析模式的HPLC制备了纯青霉素N。当用I代替青霉素N作为头孢菌素无细胞生物合成的底物时,未观察到去乙酰氧头孢菌素C(II)的形成。还在无细胞系统中测试了一种合成的头孢烷衍生物7β-(5-D-氨基己二酰胺基)-3-亚甲基头孢烷-4α-羧酸(III)作为可能的中间体。化合物III被证明是将青霉素N转化为去乙酰氧头孢菌素C的环扩展酶的抑制剂。